These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 1369643)
1. Uveitis in patients with Graves' disease. Mizoguchi T; Amemiya T Metab Pediatr Syst Ophthalmol (1985); 1991; 14(2):42-3. PubMed ID: 1369643 [TBL] [Abstract][Full Text] [Related]
2. Human T lymphotropic virus type 1 uveitis after Graves' disease. Yamaguchi K; Mochizuki M; Watanabe T; Yoshimura K; Shirao M; Araki S; Miyata N; Mori S; Kiyokawa T; Takatsuki K Br J Ophthalmol; 1994 Mar; 78(3):163-6. PubMed ID: 8148330 [TBL] [Abstract][Full Text] [Related]
3. HTLV-1 uveitis and Graves' disease presenting with sudden onset of blurred vision. Kamoi K; Uchimaru K; Tojo A; Watanabe T; Ohno-Matsui K Lancet; 2022 Jan; 399(10319):60. PubMed ID: 34973718 [No Abstract] [Full Text] [Related]
4. Human T-lymphotropic virus type I-associated uveitis in patients with Graves' disease treated with methylmercaptoimidazole. Mizokami T; Okamura K; Kohno T; Sato K; Ikenoue H; Kuroda T; Inokuchi K; Fujishima M J Clin Endocrinol Metab; 1995 Jun; 80(6):1904-7. PubMed ID: 7775639 [TBL] [Abstract][Full Text] [Related]
5. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy. Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908 [TBL] [Abstract][Full Text] [Related]
6. Hashimoto's thyroiditis following Graves' disease. Umar H; Muallima N; Adam JM; Sanusi H Acta Med Indones; 2010 Jan; 42(1):31-5. PubMed ID: 20305330 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous occurrence of Graves' disease with endocrine ophthalmopathy. Thyroiditis and thyroid carcinoma. Csáky G; Balázs G; Lukács G; Szokol M; Erdei I; Balázs C; Kincses E Acta Chir Acad Sci Hung; 1982; 23(2):117-26. PubMed ID: 6897757 [TBL] [Abstract][Full Text] [Related]
8. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948 [TBL] [Abstract][Full Text] [Related]
9. Association of HLA antigen BW35 with severe Graves' ophthalmopathy. Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ; Sanford CA Invest Ophthalmol Vis Sci; 1983 Jan; 24(1):124-7. PubMed ID: 6600737 [TBL] [Abstract][Full Text] [Related]
10. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease. Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863 [TBL] [Abstract][Full Text] [Related]
11. Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center. Tanda ML; Piantanida E; Liparulo L; Veronesi G; Lai A; Sassi L; Pariani N; Gallo D; Azzolini C; Ferrario M; Bartalena L J Clin Endocrinol Metab; 2013 Apr; 98(4):1443-9. PubMed ID: 23408569 [TBL] [Abstract][Full Text] [Related]
12. Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves' disease. Takasu N; Kamijo K; Sato Y; Yoshimura H; Nagata A; Ochi Y Clin Exp Pharmacol Physiol; 2004; 31(5-6):314-9. PubMed ID: 15191404 [TBL] [Abstract][Full Text] [Related]
13. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment. Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034 [TBL] [Abstract][Full Text] [Related]
14. Graves' disease and thyroid cancer. Behar R; Arganini M; Wu TC; McCormick M; Straus FH; DeGroot LJ; Kaplan EL Surgery; 1986 Dec; 100(6):1121-7. PubMed ID: 3787468 [TBL] [Abstract][Full Text] [Related]
15. Does Graves' disease or thyrotoxicosis affect the prognosis of thyroid cancer. Hales IB; McElduff A; Crummer P; Clifton-Bligh P; Delbridge L; Hoschl R; Poole A; Reeve TS; Wilmshurst E; Wiseman J J Clin Endocrinol Metab; 1992 Sep; 75(3):886-9. PubMed ID: 1517381 [TBL] [Abstract][Full Text] [Related]
16. Multicentre study of thyroid nodules in patients with Graves' disease. Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060 [TBL] [Abstract][Full Text] [Related]
17. HLA and Graves' disease: an association with HLA-DRw3. Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402 [TBL] [Abstract][Full Text] [Related]
18. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition. Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093 [TBL] [Abstract][Full Text] [Related]
19. Acute pericarditis: unique comorbidity of thyrotoxic crisis with Graves' disease. Inami T; Seino Y; Goda H; Okazaki H; Shirakabe A; Yamamoto M; Okajima F; Emoto N; Hata N; Shimizu W Int J Cardiol; 2014 Feb; 171(3):e129-30. PubMed ID: 24411211 [No Abstract] [Full Text] [Related]